BROOKS
Start SIP
Invest Now
Start SIP in BROOKS
Brooks Laboratories live price: ₹62.18. It opened at ₹61 vs previous close ₹61; intraday high/low: ₹63/₹60. The 50 & 200 DMA stand at ₹72.02/₹102.04.
Brooks Laboratories Performance
- Low
- ₹60
- High
- ₹63
- 52 Week Low
- ₹57
- 52 Week High
- ₹164
- Open Price₹61
- Previous Close₹61
- Volume25,854
- 50 DMA₹72.02
- 100 DMA₹85.14
- 200 DMA₹102.04
Investment Returns
- Over 1 Month -20.42%
- Over 3 Month -36.51%
- Over 6 Month -59.24%
- Over 1 Year -40.77%
Smart Investing Starts Here Start SIP with Brooks Laboratories for Steady Growth!
Brooks Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 8.5
- PEG Ratio
- 0
- Market Cap Cr
- 183
- P/B Ratio
- 1.6
- Average True Range
- 4.05
- EPS
- 7.33
- Dividend Yield
- 0
- MACD Signal
- -2.2
- RSI
- 40.21
- MFI
- 20.86
Brooks Laboratories Financials
Brooks Laboratories Technicals
EMA & SMA
Current Price
₹62.18
+
1.27
(2.09%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹65.56
- 50 Day
- ₹72.02
- 100 Day
- ₹85.14
- 200 Day
- ₹102.04
Resistance and Support
61.43
- R3 66.43
- R2 64.51
- R1 63.35
- S1 60.27
- S2 58.35
- S3 57.19
Brooks Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-06 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-13 | Quarterly Results |
Brooks Laboratories F&O
About Brooks Laboratories
- NSE Symbol
- BROOKS
- BSE Symbol
- 533543
- ISIN
- INE650L01011
Similar Stocks to Brooks Laboratories
Brooks Laboratories FAQs
Brooks Laboratories share price is ₹62 As on 12 March, 2026 | 19:57
The Market Cap of Brooks Laboratories is ₹183.2 Cr As on 12 March, 2026 | 19:57
The P/E ratio of Brooks Laboratories is 8.5 As on 12 March, 2026 | 19:57
The PB ratio of Brooks Laboratories is 1.6 As on 12 March, 2026 | 19:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.